Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Anticipate generic drug launch
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||8-alkoxyquinolonecarboxylic acid and salts thereof|
|Abstract:||Quinolonecarboxylic acid derivatives of the following formula, ##STR1## wherein R indicates a hydrogen atom or lower alkyl group, R.sup.1 indicates a lower alkyl group, R.sup.2 indicates a hydrogen atom, amino group or nitro group, X indicates a halogen atom, and Z indicates a halogen atom, piperazino group, N-methylpiperazino group, 3-methylpiperazino group, 3-hydroxypyrrolidino group, or pyrrolidino group of the following formula, ##STR2## (here, n is 0 or 1, R.sup.3 indicates a hydrogen atom or lower alkyl group, R.sup.4 indicates a hydrogen atom, lower alkyl group or substituted lower alkyl group and R.sup.5 indicates a hydrogen atom, lower alkyl group, acyl group or alkoxycarbonyl group), the hydrates and pharmaceutically acceptable salts thereof are useful as antibacterial agents.|
|Inventor(s):||Masuzawa; Kuniyoshi (Koga, JP), Suzue; Seigo (Kuki, JP), Hirai; Keiji (Kuki, JP), Ishizaki; Takayoshi (Washimiya, JP)|
|Assignee:||Kyorin Pharmaceutical Co., Ltd. (Tokyo, JP)|
|Filing Date:||Oct 22, 1990|
|Claims:||1. A compound of the formula: ##STR27## wherein R.sup.1 is lower alkyl, X is halogen, R is hydrogen or lower alkyl, n is 0 or 1, R.sup.4 is hydrogen, lower alkyl or substituted lower alkyl and R.sup.5 is hydrogen, lower alkyl, acyl, or alkoxy carbonyl. |
2. The compound of claim 1 which is 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4- oxo-3-quinolinecarboxylic acid.
3. The compound of claim 1 which is 7-(3-aminomethyl-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-meth oxy-4-oxo-3-quinolinecarboxylic acid.
4. The compound of claim 1 which is 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylaminomethyl-1-pyrr olidinyl)-4-oxo-3-quinolinecarboxylic acid.
5. The compound of claim 1 which is 1-cyclopropyl-7-(3-ethylaminomethyl-1-pyrrolidinyl)-b 6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecaboxylic acid.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.